Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
4,030,110
-
Share change
-
+1,190
-
Total reported value
-
$108,869,000
-
Price per share
-
$27.01
-
Number of holders
-
23
-
Value change
-
+$32,000
-
Number of buys
-
1
Institutional Holders of ENZYMOTEC LTD - SHS (ENZY) as of Q4 2013
As of 31 Dec 2013,
ENZYMOTEC LTD - SHS (ENZY) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,030,110 shares.
The largest 10 holders included
PAULSON & CO INC, Visium Asset Management, LP, FMR LLC, GILDER GAGNON HOWE & CO LLC, BlackRock Advisors LLC, March Altus Capital Management LP, BlackRock Group LTD, ALYDAR PARTNERS LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, and GOLDMAN SACHS GROUP INC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.